Reporter (Media and Entertainment)
ENTERTAINMENT: Election of Donald Trump credited for clients’ new engagement.
Talent agencies offer direction to clients looking to act on political and social issues.
Monica C. Lozano approached her stewardship of Spanish-language newspaper La Opinión as a family business that provided a voice for immigrant, Latino communities.
Monica C. Lozano worked to deliver more than just news to the Latino community while running La Opinión.
Creative Artists Agency has partnered with China’s CMC Capital Partners, a leading investment fund in the media and entertainment, internet and mobile, and lifestyle sectors.
Molecular diagnostics firm NantOmics, a subsidiary of billionaire Patrick Soon-Shiong’s Culver City-based NantWorks, has acquired Genos, a genetic sequencing company.
ENTERTAINMENT: Pair of Hollywood families casts lot with Glendale development.
Families with showbiz histories will raise the curtain on a theater-anchor mixed-use development.
PBS SoCal’s KOCE-TV public broadcasting station is among 175 nationwide winners of the Federal Communications Commission’s first-ever Broadcast Incentive Auction.
On-location filming in Greater Los Angeles decreased by 2.1 percent in the first quarter of 2017, according to statistics released today by FilmL.A. Inc. Among all filming categories, on-location feature film production suffered the steepest quarterly decline, slipping 36 percent and dropping to levels not seen since 2012. The decline occurred despite increase in tax credit use, the film office said.
Netflix Chief Content Officer Ted Sarandos said the company intends to bring as much Netflix production as possible to California.
Music streaming service Spotify and Universal Music Group announced a multiyear global license agreement Tuesday that will allow Universal artists the option to release new albums to premium subscribers for two weeks before public distribution.
L.A. biotech billionaire Patrick Soon-Shiong’s diagnostics company, NantHealth Inc., reported this week it lost $184 million last year, largely due to lagging sales of its much-touted GPS Cancer diagnostic test.